Top

Published in:

Open Access 01-10-2020 | Aortic Valve Replacement | Original Paper

Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors

Authors: Linghe Wu, R. W. Emmens, J. van Wezenbeek, W. Stooker, C. P. Allaart, A. B. A. Vonk, A. C. van Rossum, H. W. M. Niessen, P. A. J. Krijnen

Published in: Clinical Research in Cardiology | Issue 10/2020

Abstract

Objective

Inflammation of the atria is an important factor in the pathogenesis of atrial fibrillation (AF). Whether the extent of atrial inflammation relates with clinical risk factors of AF, however, is largely unknown. This we have studied comparing patients with paroxysmal and long-standing persistent/permanent AF.

Methods

Left atrial tissue was obtained from 50 AF patients (paroxysmal = 20, long-standing persistent/permanent = 30) that underwent a left atrial ablation procedure either or not in combination with coronary artery bypass grafting and/or valve surgery. Herein, the numbers of CD45+ and CD3+ inflammatory cells were quantified and correlated with the AF risk factors age, gender, diabetes, and blood CRP levels.

Results

The numbers of CD45+ and CD3+ cells were significantly higher in the adipose tissue of the atria compared with the myocardium in all AF patients but did not differ between AF subtypes. The numbers of CD45+ and CD3+ cells did not relate significantly to gender or diabetes in any of the AF subtypes. However, the inflammatory infiltrates as well as CK-MB and CRP blood levels increased significantly with increasing age in long-standing persistent/permanent AF and a moderate positive correlation was found between the extent of atrial inflammation and the CRP blood levels in both AF subtypes.

Conclusion

The extent of left atrial inflammation in AF patients was not related to the AF risk factors, diabetes and gender, but was associated with increasing age in patients with long-standing persistent/permanent AF. This may be indicative for a role of inflammation in the progression to long-standing persistent/permanent AF with increasing age.

Graphic abstract

Harada M, Van Wagoner DR, Nattel S (2015) Cardiovascular PathologyRole of inflammation in atrial fibrillation pathophysiology and management. Circ J 79(3):495–502CrossRef

Khan AA, Boriani G, Lip GYH (2019) Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01545-4CrossRefPubMedPubMedCentral

Benjamin Emelia J, Blaha Michael J, Chiuve Stephanie E, Cushman M, Das Sandeep R, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi Carmen R, Jiménez Monik C, Jordan Lori C, Judd Suzanne E, Lackland D, Lichtman Judith H, Lisabeth L, Liu S, Longenecker Chris T, Mackey Rachel H, Matsushita K, Mozaffarian D, Mussolino Michael E, Nasir K, Neumar Robert W, Palaniappan L, Pandey Dilip K, Thiagarajan Ravi R, Reeves Mathew J, Ritchey M, Rodriguez Carlos J, Roth Gregory A, Rosamond Wayne D, Sasson C, Towfighi A, Tsao Connie W, Turner Melanie B, Virani Salim S, Voeks Jenifer H, Willey Joshua Z, Wilkins John T, Wu Jason HY, Alger Heather M, Wong Sally S, Muntner P (2017) Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135(10):e146–e603. https://doi.org/10.1161/CIR.0000000000000485CrossRefPubMedPubMedCentral

Anderson SG, Shoaib A, Myint PK, Cleland JG, Hardman SM, McDonagh TA, Dargie H, Keavney B, Garratt CJ, Mamas MA (2019) Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit. Clin Res Cardiol 108(11):1276–1286. https://doi.org/10.1007/s00392-019-01463-5CrossRefPubMedPubMedCentral

Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375CrossRef

Fink T, Metzner A, Willems S, Eckardt L, Ince H, Brachmann J, Spitzer SG, Deneke T, Schmitt C, Hochadel M, Senges J, Rillig A (2019) Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the German Ablation Registry. Clin Res Cardiol 108(12):1354–1363. https://doi.org/10.1007/s00392-019-01471-5CrossRefPubMed

Huxley RR, Filion KB, Konety S, Alonso A (2011) Meta-analysis of cohort and case–control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 108(1):56–62CrossRef

Hu Y-F, Chen Y-J, Lin Y-J, Chen S-A (2015) Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 12(4):230–243CrossRef

Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104(24):2886–2891CrossRef

10.

Smorodinova N, Bláha M, Melenovský V, Rozsívalová K, Přidal J, Ďurišová M, Pirk J, Kautzner J, Kučera T (2017) Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm. PLoS One 12(2):e0172691CrossRef

11.

Begieneman MP, Rijvers L, Kubat B, Paulus WJ, Vonk AB, van Rossum AC, Schalkwijk CG, Stooker W, Niessen HW, Krijnen PA (2015) Atrial fibrillation coincides with the advanced glycation end product Nε-(carboxymethyl) lysine in the atrium. Am J Pathol 185(8):2096–2104CrossRef

12.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962CrossRef

13.

Santema BT, Chan MMY, Tromp J, Dokter M, van der Wal HH, Emmens JE, Takens J, Samani NJ, Ng LL, Lang CC, van der Meer P, Ter Maaten JM, Damman K, Dickstein K, Cleland JG, Zannad F, Anker SD, Metra M, van der Harst P, de Boer RA, van Veldhuisen DJ, Rienstra M, Lam CSP, Voors AA (2019) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01513-yCrossRefPubMedPubMedCentral

14.

Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D (2010) Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7(4):438–444CrossRef

15.

Peikert A, Kaier K, Merz J, Manhart L, Schafer I, Hilgendorf I, Hehn P, Wolf D, Willecke F, Sheng X, Clemens A, Zehender M, von Zur MC, Bode C, Zirlik A, Stachon P (2019) Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01511-0CrossRefPubMedPubMedCentral

16.

Schnitt SJ, Ciano PS, Schoen FJ (1987) Quantitation of lymphocytes in endomyocardial biopsies: use and limitations of antibodies to leukocyte common antigen. Hum Pathol 18(8):796–800. https://doi.org/10.1016/S0046-8177(87)80053-9CrossRefPubMed

17.

Mazurek T, Kiliszek M, Kobylecka M, Skubisz-Głuchowska J, Kochman J, Filipiak K, Królicki L, Opolski G (2014) Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol 113(9):1505–1508CrossRef

18.

Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’brien S, Keiper EA, Johnson AG (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466CrossRef

19.

Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Investig 123(3):958–965CrossRef

20.

Haemers P, Hamdi H, Guedj K, Suffee N, Farahmand P, Popovic N, Claus P, LePrince P, Nicoletti A, Jalife J (2015) Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J 38(1):53–61CrossRef

21.

Watanabe T, Takeishi Y, Hirono O, Itoh M, Matsui M, Nakamura K, Tamada Y, Kubota I (2005) C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels 20(2):45–49CrossRef

22.

Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT (2005) Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95(6):764–767CrossRef

23.

Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W (1998) Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 113(5):1290–1295. https://doi.org/10.1378/chest.113.5.1290CrossRefPubMed

24.

Dybdahl B, Wahba A, Lien E, Flo Trude H, Waage A, Qureshi N, Sellevold Olav FM, Espevik T, Sundan A (2002) Inflammatory response after open heart surgery. Circulation 105(6):685–690. https://doi.org/10.1161/hc0602.103617CrossRefPubMed

25.

Zakkar M, Ascione R, James AF, Angelini GD, Suleiman MS (2015) Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther 154:13–20. https://doi.org/10.1016/j.pharmthera.2015.06.009CrossRefPubMed

26.

Melby SJ, George JF, Picone DJ, Wallace JP, Davies JE, George DJ, Kirklin JK (2015) A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery. J Thorac Cardiovasc Surg 149(3):886–892. https://doi.org/10.1016/j.jtcvs.2014.11.032CrossRefPubMed

27.

De Backer O, Butt JH, Wong YH, Torp-Pedersen C, Terkelsen CJ, Nissen H, Fosbol EL, Kober L, Sondergaard L (2019) Early and late risk of ischemic stroke after TAVR as compared to a nationwide background population. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01565-0CrossRefPubMed

28.

Semmler V, von Krogh F, Haller B, Reents T, Bourier F, Telishevska M, Kottmaier M, Kornmayer M, Brooks S, Koch-Buttner K, Lennerz C, Brkic A, Grebmer C, Blazek P, Weigand S, Hessling G, Kolb C, Deisenhofer I (2019) The incidence, indications and predictors of acute pacemaker implantation after ablation of persistent atrial fibrillation. Clin Res Cardiol 108(6):651–659. https://doi.org/10.1007/s00392-018-1393-1CrossRefPubMed

Title: Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors
Authors: Linghe Wu
R. W. Emmens
J. van Wezenbeek
W. Stooker
C. P. Allaart
A. B. A. Vonk
A. C. van Rossum
H. W. M. Niessen
P. A. J. Krijnen
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Aortic Valve Replacement
Atrial Fibrillation
Aortic Valve Replacement
Aortic Valve Replacement
CABG
CABG
Published in: Clinical Research in Cardiology / Issue 10/2020
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-020-01619-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors

Abstract

Objective

Methods

Results

Conclusion

Graphic abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Graphic abstract

Please log in to get access to this content

Other articles of this Issue 10/2020

Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement

Long-term outcome after thrombus aspiration in non-ST-elevation myocardial infarction: results from the TATORT-NSTEMI trial

Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial

Correction to: Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial

Prognostic impact of potassium levels in patients with ventricular tachyarrhythmias

Compared with matched controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischemic stroke, heart failure and mortality even after adjustment for AF

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page